Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk of Hepatitis B Reactivation After Hematopoietic Stem Cell Transplantation in Donors and Recipients With Prior HBV Exposure

NCT01481649 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT01481649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01481649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk of Hepatitis B Reactivation After Hematopoietic Stem Cell Transplantation in Donors and Recipients With Prior HBV Exposure
Lead sponsor
The University of Hong Kong
Phase
Observational
Overall status
Completed
Start date
November 30, 2011
Completion date
February 29, 2016
Enrollment
69 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

exposure to hepatitis b virus